Natrox is a wound care company that offers innovative technologies for healthcare professionals for chronic wounds.
Natrox has raised $33.0M in total funding. The most recent round was Series C. The last funding was announced in December 2024.
Natrox's investors include Praetura Ventures, Amadeus Capital Partners, Parkwalk Advisors, Boundary Capital Partners LLP, Puhua Capital.
Natrox is headquartered in Cambridge, United Kingdom.
Natrox is a wound care company that offers innovative technologies for healthcare professionals for chronic wounds.
Natrox is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Natrox — Funding & Investors." VCBacked, December 2, 2024, https://www.vcbacked.co/company/natrox. Accessed October 31, 2026.
VCBacked. (2024). Natrox — Funding & Investors. Retrieved October 31, 2026, from https://www.vcbacked.co/company/natrox
{{cite web |title=Natrox — Funding & Investors |url=https://www.vcbacked.co/company/natrox |website=VCBacked |access-date=October 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated